News in Pakistan
TORONTO/MONTREAL (Reuters) – Johnson & Johnson’s Remicade, a blockbuster drug that treats autoimmune disorders, has steadily lost market share among patients enrolled in the Canadian province of Quebec’s public drug …
Read More
(Reuters) – A 17-year-old Michigan boy facing “imminent death” from vaping injuries has undergone a double lung transplant, the first in a patient suffering from the effects of e-cigarettes, a …
Read More
(Reuters Health) – White mothers may receive more pain assessments after delivery and have better access to painkillers than women from other racial and ethnic groups, two new studies suggest. …
Read More (Reuters) – Amarin Corp Plc’s fish oil-derived drug received a largely positive review from FDA staffers on Tuesday, dispelling investor fears that the company’s choice of placebo in its trial …
Read More
FILE PHOTO: Japan Tobacco Inc. displays “heat-not-burn” tobacco devices Ploom TECH+ (L) and Ploom S during the unveiling in Tokyo, Japan, January 17, 2019. REUTERS/Taiga Uranaka/File Photo TOKYO (Reuters) – …
Read More
SAN FRANCISCO (Reuters) – Alphabet Inc’s (GOOGL.O) Google has signed its biggest cloud computing customer in healthcare to date, in a deal giving it access to datasets that could help …
Read More
FILE PHOTO: Berkeley Medical Center Laboratory Manager Tambry Harvey displays the Klebsiella pneumonia organism in Martinsburg, West Virginia, U.S., December 7, 2016. REUTERS/Gary Cameron/File Photo LONDON (Reuters) – Pneumonia killed …
Read More (Reuters Health) – Only about 60% of lung cancer patients get recommended treatments like chemotherapy and radiation that are linked to better survival odds, and a new study suggests rates …
Read More LAGOS (Reuters) – Thousands of people with mental health conditions are held in chains in institutions across Nigeria, Human Rights Watch said in a report published on Monday in which …
Read More
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann ZURICH (Reuters) – Roche’s bid to rival Biogen and …
Read More